Drug trial for Kids' rare lung disease halted early
NCT ID NCT02615938
Summary
This study tested whether the drug hydroxychloroquine could help children with rare, chronic lung scarring diseases breathe easier. It was a small, early-phase trial that was terminated before completion. Researchers looked at whether starting or stopping the medication affected children's oxygen levels, breathing rates, and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charité Berlin, Klinik für Pädiatrie
Berlin, 13353, Germany
-
Justus-Liebig-Universität, Allgemeine Pädiatrie u. Neonatologie
Giessen, Hesse, 35385, Germany
-
Klinik u. Poliklinik für Kinder- u. Jugendmedizin der Universität Leipzig
Leipzig, Saxony, 04103, Germany
-
Klinikum der Universität München, Haunersches Kinderspital
München, Bavaria, 80337, Germany
-
Medizinische Hochschule Hannover
Hanover, Lower Saxony, 30625, Germany
-
St. Joseph- und St. Elisabeth Hospital gGmbH
Bochum, North Rhine-Westphalia, 44791, Germany
-
Uniklinikum Essen, Pädiatrische Pneumologie
Essen, North Rhine-Westphalia, 45122, Germany
-
Universitätsklinik für Kinder- und Jugendmedizin Tübingen
Tübingen, Baden-Wurttemberg, 72076, Germany
-
Universitätsklinikum Frankfurt, Pneumologie, Allergologie, Mukoviszidose
Frankfurt am Main, Hesse, 60590, Germany
Conditions
Explore the condition pages connected to this study.